Shane Storey News Today

In a report released on January 31, Shane Storey from Wilsons maintained a Hold rating on Next Science Ltd (NXSCF – Research Report), with...

Wilsons analyst Shane Storey upgraded Next Science Ltd (NXSCF – Research Report) to a Buy today and set a price target of A$0.57. The comp...

Wilsons analyst Shane Storey maintained a Hold rating on Next Science Ltd (NXSCF – Research Report) on July 28 and set a price target of A...

Wilsons analyst Shane Storey maintained a Hold rating on Nanosonics Limited (NNCSF – Research Report) on April 21 and set a price target o...

Head of research and development Bill Mezzanotte said the cost of bringing a treatment like its Hemgenix to market exceeded $US1 billion ($1.49 billion)

The CSL Limited (ASX: CSL) share price is holding above the $300 mark today amid brokers updating their ratings on the healthcare stock.

CSL investors have been waiting to hear about the blood product giant’s strategy for Vifor after a $US12bn acquisition.

Charleston is well-known in Arkansas as a small-school football power thats won multiple state championships.

Ventilator and sleep products maker ResMed has been on a rollercoaster two years. Are its shares a good buy after their recent price falls?

Ventilator and sleep products maker ResMed has been on a rollercoaster for two years. Are its shares a good buy after their recent price falls?